pharmaceutical-investing RAMM Pharma Announces Approval and Registration of Epifractán™ 2 Percent by Peru’s Ministry of Health
pharmaceutical-investing RAMM Pharma Announces Approval and Registration of Epifractán™ 5 Percent by Peru’s Ministry of Health and Enters Distribution Agreement to Supply Pharmacies in Peru
RAMM Pharma Corp. Announces Closing of Business Combination with RAMM Pharma Holdings Corp., Medic Plast S.A. and Yurelan S.A.
RAMM Pharma Corp. (formerly MTC Growth Fund-I Inc.) Announces Closing of Business Combination with RAMM Pharma Holdings Corp., Medic Plast S.A. and Yurelan S.A.; Trading Anticipated to Commence November 8, 2019
